Skip To Main Content
Homa Attar Cohen on Muck Rack

Homa Attar Cohen

As seen in: Nature
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Homa Attar

Contact Homa Attar, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

An updated framework for SARS-CoV-2 variants reflects the unpredictability of viral evolution - Nature Medicine

|
By Lorenzo Subissi, Homa Attar Cohen, Laith J Abu-Raddad, Erik Alm, Wendy Barclay, Jinal N. Bhiman, Tulio de Oliveira, Christian Drosten, Elodie Ghedin, Bart L Haagmans, Christian T. Happi, Zyleen Kassamali, Yee-Sin Leo, Marco Marklewitz, Nada M Melhem, Vincent J. Munster, Djin-Ye Oh, Thomas Peacock, Malik Peiris, Andrew Rambaut, Erik M Volz, Karin von Eije, Anne von Gottberg
| Nature Verified
The World Health Organization framework for tracking SARS-CoV-2 variants has been updated to reflect the continued evolution of the virus; this framework could be adapted for other emerging respiratory diseases with epidemic and pandemic potential.
Open in Who Shared Issue with article?

When to update COVID-19 vaccine composition - Nature Medicine

|
By Rebecca Grant, Jilian Sacks, Cheryl Cohen, J. Figueroa, David Goldblatt, Hideki Hasegawa, Oyewale Tomori, Youchun Wang, Homa Attar Cohen, Lorenzo Subissi, James R. Otieno
| Nature Verified
Vaccines against different SARS-CoV-2 variants have been approved, but continued surveillance is needed to determine when the antigen composition of vaccines should be updated, together with clinical studies to assess vaccine efficacy. Entering the fourth year of the COVID-19 pandemic, index virus-based1 vaccines across several different platforms continue to provide high levels of protection against severe disease caused by all variants of SARS-CoV-2, including Omicron2.
Open in Who Shared Issue with article?
See all 2 licensed articles (3 Total)